Clive G. Ballard, MRC

Original Research

Memantine for Agitation/Aggression and Psychosis in Moderately Severe to Severe Alzheimer's Disease: A Pooled Analysis of 3 Studies

March 14, 2008

Gordon K. Wilcock, Clive G. Ballard, James A. Cooper, et al

Original Research

Neuroleptic Sensitivity in Parkinson's Disease and Parkinsonian Dementias

May 15, 2005

Dag Aarsland, Robert Perry, Jan P. Larsen, et al

Article

The Relationship Between Antipsychotic Treatment and Quality of Life for Patients With Dementia Living in Residential and Nursing Home Care Facilities

July 1, 2004

Clive G. Ballard, Marisa L. Margallo-Lana

Original Research

A 3-Month, Randomized, Placebo-Controlled, Neuroleptic Discontinuation Study in 100 People With Dementia: The Neuropsychiatric Inventory Median Cutoff Is a Predictor of Clinical Outcome

January 1, 2004

Clive G. Ballard, Alan Thomas, Jane Fossey, et al

Letter to the Editor

Reply to Reporting Changes in Scores on the Cohen-Mansfield Agitation Inventory Subscales

June 15, 2003

Clive G. Ballard

Original Research

Aromatherapy as a Safe and Effective Treatment for the Management of Agitation in Severe Dementia: The Results of a Double-Blind, Placebo-Controlled Trial With Melissa

July 16, 2002

Clive G. Ballard, John T. O'Brien, Katharina Reichelt, et al

Original Research

A 1-Year Follow-Up Study of Behavioral and Psychological Symptoms in Dementia Among People in Care Environments.

August 1, 2001

Clive G. Ballard, Marisa Margallo-Lana, Jane Fossey, et al

Original Research

The Natural History of Psychosis and Depression in Dementia With Lewy Bodies and Alzheimer's Disease: Persistence and New Cases Over 1 Year of Follow-Up

January 1, 2001

Clive G. Ballard, John T. O'Brien, Alan G. Swann, et al

Memantine for Agitation/Aggression and Psychosis in Moderately Severe to Severe Alzheimer's Disease: A Pooled Analysis of 3 Studies

Neuroleptic Sensitivity in Parkinson's Disease and Parkinsonian Dementias

The Relationship Between Antipsychotic Treatment and Quality of Life for Patients With Dementia Living in Residential and Nursing Home Care Facilities

A 3-Month, Randomized, Placebo-Controlled, Neuroleptic Discontinuation Study in 100 People With Dementia: The Neuropsychiatric Inventory Median Cutoff Is a Predictor of Clinical Outcome

Reply to Reporting Changes in Scores on the Cohen-Mansfield Agitation Inventory Subscales

Aromatherapy as a Safe and Effective Treatment for the Management of Agitation in Severe Dementia: The Results of a Double-Blind, Placebo-Controlled Trial With Melissa

A 1-Year Follow-Up Study of Behavioral and Psychological Symptoms in Dementia Among People in Care Environments.

The Natural History of Psychosis and Depression in Dementia With Lewy Bodies and Alzheimer's Disease: Persistence and New Cases Over 1 Year of Follow-Up

ELSEWHERE:

FOLLOW US:

Clive G. Ballard, MRC

Memantine for Agitation/Aggression and Psychosis in Moderately Severe to Severe Alzheimer's Disease: A Pooled Analysis of 3 Studies

Neuroleptic Sensitivity in Parkinson's Disease and Parkinsonian Dementias

The Relationship Between Antipsychotic Treatment and Quality of Life for Patients With Dementia Living in Residential and Nursing Home Care Facilities

A 3-Month, Randomized, Placebo-Controlled, Neuroleptic Discontinuation Study in 100 People With Dementia: The Neuropsychiatric Inventory Median Cutoff Is a Predictor of Clinical Outcome

Reply to Reporting Changes in Scores on the Cohen-Mansfield Agitation Inventory Subscales

Aromatherapy as a Safe and Effective Treatment for the Management of Agitation in Severe Dementia: The Results of a Double-Blind, Placebo-Controlled Trial With Melissa

A 1-Year Follow-Up Study of Behavioral and Psychological Symptoms in Dementia Among People in Care Environments.

The Natural History of Psychosis and Depression in Dementia With Lewy Bodies and Alzheimer's Disease: Persistence and New Cases Over 1 Year of Follow-Up

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles